1. Home
  2. Analysis
  3. Ibrance
  4. Xeroderma

Ibrance and Xeroderma - a phase IV clinical study of FDA data

Summary:

Xeroderma is reported as a side effect among people who take Ibrance (palbociclib), especially for people who are female, 60+ old, also take Calcium, and have Retroperitoneal cancer.

The phase IV clinical study analyzes which people have Xeroderma when taking Ibrance. It is created by eHealthMe based on reports of 104,340 people who have side effects when taking Ibrance from the FDA, and is updated regularly.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,433 Ibrance users. Check the latest studies of Ibrance.

What is Xeroderma?

Xeroderma (dry skin include itching and red, cracked or flaky skin) is found to be associated with 62 drugs and 285 conditions by eHealthMe. Check the latest studies of Xeroderma.

On Nov, 29, 2025

104,340 people reported to have side effects when taking Ibrance.
Among them, 7 people (0.01%) have Xeroderma.

Could Ibrance cause Xeroderma?

Among these 7 people:

What is the gender of people who have Xeroderma when taking Ibrance? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Xeroderma when taking Ibrance? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 14.29 %
  • 50-59: 42.86 %
  • 60+: 42.86 %

What are other drugs people take besides Ibrance? *

  1. Vitamin D3: 2 people, 28.57%
  2. Sucralfate: 2 people, 28.57%
  3. Lysine: 2 people, 28.57%
  4. Hydrocodone Bitartrate And Acetaminophen: 2 people, 28.57%
  5. Gabapentin: 2 people, 28.57%
  6. Coenzyme Q10: 2 people, 28.57%
  7. Calcium: 2 people, 28.57%
  8. Zoladex: 1 person, 14.29%
  9. Vitamin E: 1 person, 14.29%
  10. Tylenol: 1 person, 14.29%

What are other side effects people have besides Xeroderma? *

  1. Fatigue (feeling of tiredness): 5 people, 71.43%
  2. Dry Skin: 5 people, 71.43%
  3. Hair Loss: 4 people, 57.14%
  4. Skin Exfoliation (removal of the oldest dead skin cells): 3 people, 42.86%
  5. Skin Haemorrhage (bleeding into skin): 2 people, 28.57%
  6. Itching: 2 people, 28.57%
  7. Memory Loss: 2 people, 28.57%
  8. Nail Disorder (disease of nail): 2 people, 28.57%
  9. Onychoclasis (breaking of the nails): 2 people, 28.57%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 28.57%

What are the existing conditions these people have? *

  1. Retroperitoneal Cancer (cancer between the peritoneum and the posterior abdominal wall): 2 people, 28.57%
  2. Weight Increased: 1 person, 14.29%
  3. Pain: 1 person, 14.29%
  4. Oedema (fluid collection in tissue): 1 person, 14.29%
  5. Breast Cancer Female: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Ibrance and have Xeroderma?

- Check whether Xeroderma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ibrance:

Xeroderma treatments and more:

How severe was Xeroderma and when was it recovered:

Expand to all the drugs that have ingredients of palbociclib:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ibrance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Xeroderma:

Browse all the conditions that are associated with Xeroderma:

How the study uses the data?

The study uses data from the FDA. It is based on palbociclib (the active ingredients of Ibrance) and Ibrance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2025 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.